Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
4.0
-29.03%
40%
—
25.77%
60%
—
5 Years
Score4.0
Net Growth-29.03%
Net Trend40%
Net Income Consistency—
Rev Growth25.77%
Rev Trend60%
Revenue Consistency—
10X Genomics Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 298M to $ 642M and net income went from -$ 542M to -$ 43M. Revenue increased in 3 of those 5 years; net income in 2.
10X Genomics Inc currently holds a 5-year HDB Score of 4.0 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 57.75 | — |
1 Year2025-08-12 | $ 12.81 | 350.82% |
5 Years2021-08-12 | $ 161.21 | -64.18% |
All Time2019-09-12 | $ 52.75 | 9.48% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2019-09-12 |
|---|---|---|---|---|
| Price | $ 57.75 | $ 12.81 | $ 161.21 | $ 52.75 |
| Return | — | 350.82% | -64.18% | 9.48% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 616M | -$ 75M | $ 552M |
| 2025 | $ 642M | -$ 43M | $ 523M |
| 2024 | $ 610M | -$ 182M | $ 393M |
| 2023 | $ 618M | -$ 255M | $ 388M |
| 2022 | $ 516M | -$ 166M | $ 429M |
| 2021 | $ 490M | -$ 58M | $ 587M |
| 2020 | $ 298M | -$ 542M | $ 663M |
| IPO2019 | $ 245M | -$ 31M | $ 424M |
Explore beyond TXG
You're looking at 10X Genomics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
